For global contact information please click here
|
For more information, please click here to access the Lundbeck Clinical Trial Registry.
|
| Publication title | Author | Source | Drug | Year |
| The novel adenosine A2Aantagonist Lu AA47070 reverses the motor and motivational effects produced by dopamine D2 receptor blockade | Collins LE, Sager TN, Sams AG, Pennarola A, Port RG, Shahriari M, Salamone JD | Pharmacology Biochemistry and Behavior 2012;100:498-505 | - | 2012 |
| Benzodiazepine discontinuation with prolonged-release melatonin: Hints from a German longitudinal prescription database | Kunz D, Bineau S, Maman K, Milea D, Toumi M | Expert Opinion on Pharmacotherapy 2012;13(1):9-16 | - | 2012 |
| Characterization of ((3)H)Lu AE60157 (((3)H)8-(4-methylpiperazin-1-yl)-3-phenylsulfonylquinoline) binding to 5-hydroxytryptamine6 (5-HT(6)) receptors in vivo | Witten L, Bang-Andersen B, Nielsen SM, Miller S, Christoffersen CT, Stensbol TB, Brennum LT, Arnt J | European journal of pharmacology 2012;676:6-11 | Sertindole | 2012 |
| Cardiovascular fitness is associated with altered cortical glucose metabolism during working memory in Epsilon4 carriers | Deeny SP, Winchester J, Nichol K, Roth SM, Wu JC, Dick M, Cotman CW | Alzheimer's and Dementia 2012. E-published: 8 January 2012 | - | 2012 |
| Design and operation of a filter reactor for continuous production of a selected pharmaceutical intermediate | Christensen KM, Pedersen MJ, Dam-Johansen K, Holm TL, Skovby T, Kiil S | Chemical Engineering Science 2012;71:111-117 | - | 2011 |
| Study of interaction between croscarmellose and escitalopram during sample preparation | Larsen J, Melander C | Drug development and industrial pharmacy 2011. E-published Dec 27 2011 | Escitalopram | 2011 |
| Asymmetric Michael Addition of Nitrobenzyl Pyridines to Enals via Iminium Catalysis | Vera S, Liu Y, Marigo M, Escudero-Adan EC, Melchiorre P | Synlett 2011;2011(4):489-494 + supporting information incl. | - | 2011 |
| The Oxygen-Mediated Synthesis of 1,3-Butadiynes in Continuous Flow: Using Teflon AF-2400 to Effect Gas/Liquid Contact | Petersen TP, Polyzos A, O'Brien M, Ulven T, Baxendale IR, Ley SV | ChemSusChem 2011. E-published online: 21 SEP 2011 | - | 2011 |
| Synthesis of N-alkylated amino acids using fluorous-tagged hydroxylamines | Nielsen SD, Smith GP, Begtrupa M, Kristensen JL | Tetrahedron 2011. E-published: 14 May 2011. | - | 2011 |
| COMT and age at onset in mood disorders: a replication and extension study | Massat I, Kocabas NA, Crisafulli C, Chiesa A, Calati R, Linotte S, Kasper S, Fink M, Antonijevic I, Forray C, Snyder L, Bollen J, Zohar J, De Ronchi D, Souery D, Serretti A, Mendlewicz J | Neuroscience Letters 2011;498:218-221 | - | 2011 |
| Asenapine for the treatment of stuttering: an analysis of three cases | Maguire GA, Franklin DL, Kirsten J | American journal of psychiatry 2011;168(6):651-652 | Asenapine | 2011 |
| Comparing Antidepressant Treatment Patterns in Older and Younger Adults: A Claims Database Analysis | Sanglier T, Saragoussi D, Milea D, Auray JP, Valuck RJ, Tournier M | Journal of the American Geriatrics Society 2011;59(7):1197-1205 | Citalopram; Escitalopram | 2011 |
| Mixing subattolitre volumes in a quantitative and highly parallel manner with soft matter nanofluidics | Christensen SM, Bolinger PY, Hatzakis NS, Mortensen MW, Dimitrios S | Nature nanotechnology 2011. E-published 30 October 2011 | - | 2011 |
| EEG spectral power density profiles during NREM sleep for gaboxadol and zolpidem in patients with primary insomnia | Lundahl J, Deacon S, Maurice D, Staner L | Journal of psychopharmacology 2011. E-published 5 November 2011 | Gaboxadol | 2011 |
| Severe and anxious depression: Combining definitions of clinical sub- types to identify patients differentially responsive to selective serotonin reuptake inhibitors | Papakostas GI, Fan H, Tedeschini E | European neuropsychopharmacology 2011. E- published: 16 Nov 2011 | Escitalopram | 2011 |
| Complexation of tauro- and glyco-conjugated bile salts with alpha- cyclodextrin and hydroxypropyl-alpha-cyclodextrin studied by affinity capillary electrophoresis and molecular modelling | Holm R, Schonbeck C, Askjar S, Jensen H, Westh P, Ostergaard J | Journal of Separation Science 2011;34(22):3221-3230 | - | 2011 |
| A randomised, double-blind, placebo controlled, duloxetine-referenced, fixed-dose study of three dosages of Lu AA21004 in acute treatment of major depressive disorder (MDD) | Baldwin DS, Loft H, Dragheim M | European Neuropsychopharmacology 2011. E-published: 30 December, 2011 | - | 2011 |
| Titanium isopropoxide/pyridine mediated Knoevenagel reactions | Robichaud BA, Liu KG | Tetrahedron Letters 2011;52(51):6935-6938 | - | 2011 |
| 5-(2'-Pyridyl)-2-aminothiazoles: Alkyl amino sulfonamides and sulfamides as potent NPY5 antagonists | Packiarajan M, Coate H, Desai M, Jimenez N, Reinhard EJ, Jubian VJ, Marzabadi MR, Chandrasena G, Wolinski TC, Walker MW, Andersen K | Bioorganic and Medicinal Chemistry Letters 2011;21(21):6500-6504 | - | 2011 |
| Effects of escitalopram on sleep problems in patients with major depression or generalized anxiety disorder | Stein DJ, Lopez AG | Advances in therapy 2011;28(11):1021-1037 | Citalopram; Escitalopram | 2011 |
| Escitalopram in Philippine clinical practice: Result of an open-label, observational study in 2920 outpatients with depression | Ong A, Lan G | Phillippine Journal of Internal Medicine 2011;49(2):100-104 | Escitalopram | 2011 |
| Negative modulation of GABA(A) alpha5 receptors by RO4938581 attenuates discrete sub-chronic and early postnatal phencyclidine (PCP)-induced cognitive deficits in rats | Redrobe JP, Elster L, Frederiksen K, Bundgaard C, de Jong IEM, Smith GP, Bruun AT, Larsen PH, Didriksen M | Psychopharmacology 2011. E-published 29 November 2011 | - | 2011 |
| Species Comparison of In Vivo P-glycoprotein Mediated Brain Efflux Using mdr1a Deficient Rats and Mice | Bundgaard C, Jensen CJN, Garmer M | Drug metabolism and disposition: the biological fate of chemicals 2011. E -published: 23 Nov 2011 | Citalopram | 2011 |
| Association Between Depression and Vascular Disease in Systemic Lupus Erythematosus | Greco CM, Li T, Sattar A, Kao AH, Danchenko N, Edmundowicz D, Sutton TK, Tracy RP, Kuller LH, Manzi S | Journal of rheumatology 2011. E-published: 15 Dec 2011 | - | 2011 |
| Pharmacological effects of Lu AA21004: a novel multimodal compound for the treatment of major depressive disorder | Mork A, Pehrson A, Brennum LT, Moller NS, Zhong H, Lassen AB, Miller S, Westrich L, Boyle NJ, Sanchez C, Fischer CW, Liebenberg N, Wegener G, Bundgaard C, Hogg S, Bang AB, Bryan Stensbøl T | Journal of pharmacology and experimental therapeutics 2011. E- published: 9 Dec 2011 | Citalopram | 2011 |